SILVERBACK THERAPEUTICS INC's ticker is SBTX and the CUSIP is 82835W108. A total of 63 filers reported holding SILVERBACK THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $34,930,553 | -40.4% | 9,240,887 | +5.7% | 0.74% | -30.1% |
Q2 2023 | $58,563,943 | +2.9% | 8,740,887 | 0.0% | 1.06% | -5.0% |
Q1 2023 | $56,903,174 | -23.7% | 8,740,887 | 0.0% | 1.12% | -21.7% |
Q4 2022 | $74,559,766 | +61.6% | 8,740,887 | 0.0% | 1.43% | +66.4% |
Q3 2022 | $46,152,000 | +24.5% | 8,740,887 | 0.0% | 0.86% | +27.5% |
Q2 2022 | $37,061,000 | +20.8% | 8,740,887 | 0.0% | 0.67% | +35.2% |
Q1 2022 | $30,681,000 | -47.3% | 8,740,887 | 0.0% | 0.50% | -33.6% |
Q4 2021 | $58,214,000 | -33.3% | 8,740,887 | 0.0% | 0.75% | -22.0% |
Q3 2021 | $87,234,000 | -67.7% | 8,740,887 | 0.0% | 0.96% | -64.9% |
Q2 2021 | $270,006,000 | -29.2% | 8,740,887 | 0.0% | 2.73% | -23.4% |
Q1 2021 | $381,365,000 | -5.8% | 8,740,887 | 0.0% | 3.57% | +0.6% |
Q4 2020 | $405,053,000 | – | 8,740,887 | – | 3.54% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Nextech Invest Ltd. | 1,910,029 | $10,085,000 | 3.26% |
K2 PRINCIPAL FUND, L.P. | 3,247,533 | $16,890,000 | 1.94% |
SECTORAL ASSET MANAGEMENT INC | 1,045,234 | $5,519,000 | 1.09% |
Orbimed Advisors | 8,740,887 | $46,152,000 | 0.86% |
Rubric Capital Management LP | 2,695,170 | $14,230,000 | 0.72% |
Prosight Management, LP | 196,257 | $1,036,000 | 0.56% |
Nantahala Capital Management | 1,249,863 | $6,599,000 | 0.43% |
Oasis Management Co Ltd. | 317,662 | $1,677,000 | 0.28% |
TANG CAPITAL MANAGEMENT LLC | 409,463 | $2,162,000 | 0.26% |
APOGEM CAPITAL LLC | 13,793 | $73,000 | 0.07% |